inhibidores de cdk4/6 cmm rh-positivo, her2-negativo: evidencia and recomendaciones
Published 1 year ago • 118 plays • Length 28:35Download video MP4
Download video MP3
Similar videos
-
1:15
inhibidores de ciclina y cáncer de mama metastásico hr /her2-
-
7:13
justificación biológica para los inhibidores de cdk4-6
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:56
toxicidades de los inhibidores de ciclina
-
4:52
cdk4/6 inhibitors in hormone receptor-positive, her2-negative metastatic breast cancer
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
2:30
localization of arl4c to invasive pseudopods accelerates pancreatic cancer cell invasion
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis
-
1:21
cdk4/6 inhibition: paloma2 versus monaleesa2
-
3:57
cdk4/6 inhibitors for metastatic breast cancer
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
3:42
cyclin-dependent kinase 4 (cdk4) inhibition and metastatic breast cancer
-
4:42
kisqali, un icdk diferente
-
4:37
case 2: cdk4/6 inhibitors in er breast cancer
-
3:24
detect er expressing disease
-
2:52
mechanisms of resistance to cdk4/6 inhibitors in triple negative breast cancer
-
6:13
case 2: cdk4/6 inhibitor recommendations in er breast cancer
-
2:30
germain, adelson: fulvestrant for hr breast cancer